HK1043122A1 - 抗精神病的環狀n-芳烷基胺 - Google Patents

抗精神病的環狀n-芳烷基胺 Download PDF

Info

Publication number
HK1043122A1
HK1043122A1 HK02104681.4A HK02104681A HK1043122A1 HK 1043122 A1 HK1043122 A1 HK 1043122A1 HK 02104681 A HK02104681 A HK 02104681A HK 1043122 A1 HK1043122 A1 HK 1043122A1
Authority
HK
Hong Kong
Prior art keywords
aralkyl amines
antipsychotic
cyclic
antipsychotic cyclic
aralkyl
Prior art date
Application number
HK02104681.4A
Other languages
English (en)
Chinese (zh)
Inventor
Boigegrain Robert
Bourrie Martine
Lair Pierre
Paul Raymond
Poncelet Martine
Vernieres Jean-Claude
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of HK1043122A1 publication Critical patent/HK1043122A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK02104681.4A 1999-07-02 2000-06-27 抗精神病的環狀n-芳烷基胺 HK1043122A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9908532A FR2795724B1 (fr) 1999-07-02 1999-07-02 Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant
FR99/08532 1999-07-02
PCT/FR2000/001790 WO2001002380A1 (fr) 1999-07-02 2000-06-27 N-aralkyl amines cycliques antipsychotiques

Publications (1)

Publication Number Publication Date
HK1043122A1 true HK1043122A1 (zh) 2002-09-06

Family

ID=9547628

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02104681.4A HK1043122A1 (zh) 1999-07-02 2000-06-27 抗精神病的環狀n-芳烷基胺

Country Status (31)

Country Link
US (1) US6908914B1 (https=)
EP (1) EP1196403B1 (https=)
JP (1) JP4931309B2 (https=)
KR (1) KR100760446B1 (https=)
CN (1) CN1156462C (https=)
AR (1) AR029374A1 (https=)
AT (1) ATE309231T1 (https=)
AU (1) AU778299B2 (https=)
BG (1) BG65209B1 (https=)
BR (1) BR0012463B1 (https=)
CA (1) CA2376691C (https=)
CO (1) CO5021196A1 (https=)
CZ (1) CZ300936B6 (https=)
DE (1) DE60023898T2 (https=)
DK (1) DK1196403T3 (https=)
EA (1) EA004048B1 (https=)
ES (1) ES2250160T3 (https=)
FR (1) FR2795724B1 (https=)
HK (1) HK1043122A1 (https=)
HR (1) HRP20010949B1 (https=)
HU (1) HU228983B1 (https=)
IL (2) IL147069A0 (https=)
ME (1) MEP25508A (https=)
MX (1) MXPA01013207A (https=)
NO (1) NO322230B1 (https=)
NZ (1) NZ516342A (https=)
RS (1) RS50266B (https=)
TW (1) TWI285640B (https=)
UA (1) UA71009C2 (https=)
WO (1) WO2001002380A1 (https=)
ZA (1) ZA200200018B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE50207026D1 (de) * 2001-08-23 2006-07-06 Bayer Cropscience Sa Substituierte propargylamine
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790971A (fr) * 1971-11-09 1973-05-07 Janssen Pharmaceutica Nv Metode ter voorkoming van patologische reakties die de funktie van het komplement vereisen
JPS504086A (https=) * 1973-01-18 1975-01-16
GB1475314A (en) * 1973-11-02 1977-06-01 Cm Ind Phenyl-propylamine derivatives
US4104383A (en) * 1973-11-02 1978-08-01 C M Industries Derivatives of phenylpropenylamine
EP0347123A3 (en) * 1988-06-17 1991-07-03 Fisons Corporation Dibenzo-cycloheptenyl, -cycloheptyl and -oxepinyl amines having antihistaminic properties
US4912222A (en) * 1988-06-17 1990-03-27 Fisons Corporation Antihistamines related to cyproheptadine
US4855462A (en) * 1988-06-17 1989-08-08 Pennwalt Corporation Antihistamines
FR2663328B1 (fr) * 1990-06-14 1994-08-05 Sanofi Sa Derives d'hexahydroazepines, un procede pour leur preparation et compositions pharmaceutiques les contenant.
WO1993000313A2 (en) * 1991-06-27 1993-01-07 Virginia Commonwealth University Sigma receptor ligands and the use thereof
JP3199405B2 (ja) * 1991-08-30 2001-08-20 生化学工業株式会社 肝細胞球状集塊化剤及び球状集塊化肝細胞の製造方法
US5486517A (en) * 1994-05-10 1996-01-23 Warner-Lambert Company Benzimidazoles and imidazopyridines as central nervous system agents
FR2751645B1 (fr) * 1996-07-29 1998-12-24 Sanofi Sa Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales
JP3690423B2 (ja) * 1997-03-18 2005-08-31 スミスクライン ビーチャム パブリック リミテッド カンパニー 置換イソキノリン誘導体およびその抗痙攣薬としての使用

Also Published As

Publication number Publication date
CZ300936B6 (cs) 2009-09-16
IL147069A (en) 2006-09-05
AU5992400A (en) 2001-01-22
FR2795724A1 (fr) 2001-01-05
DE60023898T2 (de) 2006-08-10
HRP20010949B1 (en) 2006-06-30
WO2001002380A8 (fr) 2001-06-28
DE60023898D1 (de) 2005-12-15
EP1196403A1 (fr) 2002-04-17
DK1196403T3 (da) 2006-03-20
WO2001002380A1 (fr) 2001-01-11
CA2376691A1 (en) 2001-01-11
ES2250160T3 (es) 2006-04-16
IL147069A0 (en) 2002-08-14
PL356186A1 (en) 2004-06-14
EP1196403B1 (fr) 2005-11-09
HUP0202200A3 (en) 2002-12-28
CN1156462C (zh) 2004-07-07
US6908914B1 (en) 2005-06-21
JP2003503487A (ja) 2003-01-28
CZ20014697A3 (cs) 2002-04-17
UA71009C2 (uk) 2004-11-15
AU778299B2 (en) 2004-11-25
NO20016392D0 (no) 2001-12-27
BR0012463A (pt) 2002-04-02
NZ516342A (en) 2003-08-29
MEP25508A (en) 2010-06-10
CA2376691C (en) 2009-09-01
ZA200200018B (en) 2003-01-02
NO322230B1 (no) 2006-08-28
BR0012463B1 (pt) 2014-11-04
AR029374A1 (es) 2003-06-25
KR20020016877A (ko) 2002-03-06
TWI285640B (en) 2007-08-21
EA004048B1 (ru) 2003-12-25
CO5021196A1 (es) 2001-03-27
BG65209B1 (bg) 2007-07-31
FR2795724B1 (fr) 2002-12-13
HRP20010949A2 (en) 2003-04-30
JP4931309B2 (ja) 2012-05-16
BG106255A (en) 2002-10-31
HUP0202200A2 (en) 2002-10-28
CN1367783A (zh) 2002-09-04
YU91101A (sh) 2004-09-03
HU228983B1 (en) 2013-07-29
MXPA01013207A (es) 2002-06-21
EA200101209A1 (ru) 2002-06-27
NO20016392L (no) 2002-03-04
RS50266B (sr) 2009-07-15
ATE309231T1 (de) 2005-11-15
KR100760446B1 (ko) 2007-10-04

Similar Documents

Publication Publication Date Title
HUP0402161A3 (en) Nicotin-or isonicotin benzothiazole derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0200572A2 (en) Amine derivatives as protease inhibitors process for their preparation, pharmaceutical compositions containing them and their use
HUP0402264A3 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines process for preparing them, pharmaceutical compositions containing them and use thereof
HUP0301315A3 (en) Benzothiazole derivatives, process for their preparation, their use and pharmaceutical compositions containing them
WO2001046200A8 (en) Novel piperidine and piperazine derivatives
HUP0204245A3 (en) Novel n-azabicyclo-amide derivatives, process for their preparation, pharmaceutical compositions containing them and their use
PH31335A (en) Naphthalamides as central nervous system agent.
HUP0203902A3 (en) Substituted oxazolidinones, process for their preparation and pharmaceutical compositions containing them and their use
HUP0301167A3 (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders, process for their preparation, pharmaceutical compositions containing them and their use
IL141997A0 (en) Novel n-(iminomethyl) amine derivatives, their preparation, their use as medicines and compositions containing them
HUP0202787A3 (en) Piperazine derivatives as 5-ht1b antagonists, process for their preparation and pharmaceutical compositions containing them
IL156662A0 (en) Oxazolidinone derivatives, process for the preparation thereof and pharmaceutical compositions containing the same
TR200200821T2 (tr) 5-Beta-sapojenin ve pseudosapojenin türevleri ve bunların bunama tedavisinde kullanımı.
HUP0200284A3 (en) 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders, process for their preparation and pharmaceutical compositions containing them
AU2002233463A1 (en) Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use
HUP0203320A3 (en) Indolylpiperidine derivatives and their use as antihistaminic and antiallergic agents, process for their preparation, pharmaceutical compositions containing them
AU2003255612A8 (en) Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
HUP0400317A3 (en) Beta-carboline derivatives, process for their preparation, their use and pharmaceutical compositions containing them
HK1046902A1 (zh) 新型哌嗪基烷基硫代嘧啶衍生物，包含該衍生物的藥物組合物以及製備該活性物質的方法
HK1043122A1 (zh) 抗精神病的環狀n-芳烷基胺
HUP0500958A3 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them, therapeutic use thereof and pharmaceutical compositions containing them
PL370159A1 (en) Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
SI1241169T1 (en) Isoindoloindolone derivatives, process for their preparation and pharmaceutical compositions containing them
IL144363A0 (en) (1-phenacyl-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
SI1245565T1 (en) Indenoindolone derivatives, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
CHPA Change of a particular in the register (except of change of ownership)